HLA-DRB1 haplotype did not affect the medium-term results of total knee arthroplasty in patients with rheumatoid arthritis

Seisuke Takemura, Yoshitaka Toda, Jörg J. Goronzy, Cornelia M. Weyand, Ryokei Ogawa, Hirokazu Iida

Research output: Contribution to journalArticlepeer-review

Abstract

This study investigated whether the HLA-DRB1 "susceptible allele" (SA) genotype is predictive for total knee arthroplasty (TKA) failure in patients with rheumatoid arthritis (RA). The results of 49 TKAs (30 RA patients) with an average follow-up of 7.9 years (range 5-15 years) were analyzed using a 12-item questionnaire and the Knee Society system. HLA-DRB1 alleles were used to estimate the severity of RA and divide the patients into three categories depending upon the gene dose of SA (SA+/+, SA+/-, and SA-/-). For all three categories, the 12-item questionnaire had significantly improved postoperatively, but without significant difference. We divided the 12 items of the questionnaire into two groups: knee-relevant parameters and general parameters. Patients in all three groups improved similarly in knee-relevant parameters. In contrast, those homozygous for SA (SA+/+) benefited less in general parameters. The average radiolucency score was 1.87mm, with no difference being detected among the three groups. The HLA-DRB1 genotype did not affect the survival of the knee implants. Overall, patients without the RA-associated HLA gene benefited most from TKA as they improved not only in knee function, but also in parameters of general functional status.

Original languageEnglish (US)
Pages (from-to)37-42
Number of pages6
JournalModern Rheumatology
Volume14
Issue number1
DOIs
StatePublished - Mar 2004

Keywords

  • Disease severity
  • Human leukocyte antigen (HLA)
  • Rheumatoid arthritis (RA)
  • Susceptible allele (SA)
  • Total knee arthroplasty (TKA)

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'HLA-DRB1 haplotype did not affect the medium-term results of total knee arthroplasty in patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this